SLSN

MKT CAP:$82M

Solesence, Inc. Common Stock

Market Cap

$82M

Consumer Defensive·Household & Personal Products·🇺🇸 United States·NASDAQ

Consumer Def.·Household·🇺🇸·NASDAQ

Stock Price

$1.10-$0.40 (-26.67%)

Apr 21, 2026

Company Details

Solésence, Inc., formerly Nanophase Technologies Corporation, is a developer and manufacturer of clean, inclusive, mineral-based skincare and makeup products. The company partners with global and indie brands, leveraging its proprietary Act...

CEO

Kevin Cureton

IPO Date

Apr 8, 2025

Website

solesence.com

Key Metrics TTM

Revenue

$62M

+18.6% YoY

Net Income

$2M

EPS (Diluted)

$0.03

Free Cash Flow

-$10M

Revenue / Share

$0.85

Gross Margin

25.9%

Operating Margin

2.5%

Net Margin

2.9%

FCF Margin

-16.7%

P/S

1.3x

P/E

45.8x

Earnings Reports

Q1 2026

May 5, 2026

PENDING

FY 2025

Mar 31, 2026

$62M+18.6%EPS $0.02

Q4 2025

Mar 31, 2026

$12M-0.7%EPS $0.00

Q3 2025

Nov 12, 2025

$15M-13.5%EPS -$0.02

Q2 2025

Aug 14, 2025

$20M+56.1%EPS $0.04

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q4 23	$8M	$471.0K	-$2M
Q1 24	$10M	$4M	$1M
Q2 24	$13M	$4M	$1M
Q3 24	$17M	$6M	$3M
Q4 24	$13M	$3M	-$223.0K
Q1 25	$15M	$3M	$256.0K
Q2 25	$20M	$6M	$2M
Q3 25	$15M	$3M	-$781.0K
Q4 25	$12M	$3M	$186.0K

Valuation

Quarter	P/S	P/E
Q4 23	—	—
Q1 24	—	—
Q2 24	—	—
Q3 24	2.4x	42.5x
Q4 24	3.0x	37.4x
Q1 25	2.5x	42.0x
Q2 25	4.7x	58.4x
Q3 25	3.6x	210.0x
Q4 25	1.9x	67.4x

Operating Cash Flow

Quarter	Operating CF	Free CF
Q4 23	-$3M	-$3M
Q1 24	-$4M	-$4M
Q2 24	-$565.0K	-$1M
Q3 24	$4M	$3M
Q4 24	$2M	-$404.0K
Q1 25	-$7M	-$7M
Q2 25	-$654.0K	-$654.0K
Q3 25	-$3M	-$3M
Q4 25	$2M	$411.0K

Capital Expenditures

Quarter	CapEx
Q4 23	$199.0K
Q1 24	$85.0K
Q2 24	$477.0K
Q3 24	$1M
Q4 24	$3M
Q1 25	$0
Q2 25	$0
Q3 25	$418.0K
Q4 25	$1M

CapEx

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q4 24	+56.9%	+29.1%
Q1 25	+48.2%	+64.1%
Q2 25	+56.1%	+53.8%
Q3 25	-13.5%	+12.5%
Q4 25	-0.7%	-3.9%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q4 23	$0	0.0%
Q1 24	$160.0K	1.6%
Q2 24	$157.0K	1.2%
Q3 24	$160.0K	0.9%
Q4 24	$248.0K	2.0%
Q1 25	$127.0K	0.9%
Q2 25	$120.0K	0.6%
Q3 25	$122.0K	0.8%
Q4 25	$206.0K	1.7%

OpEx Breakdown

Quarter	R&D	SG&A
Q4 23	$785.0K	$2M
Q1 24	$910.0K	$2M
Q2 24	$864.0K	$2M
Q3 24	$970.0K	$2M
Q4 24	$1M	$2M
Q1 25	$1M	$2M
Q2 25	$955.0K	$3M
Q3 25	$1M	$3M
Q4 25	$1M	$2M

Revenue Segments

Quarter	Advanced Materials	Personal Care Ingredients	Solesence	Consumer Products	Personal Care ingredients
Q1 24	$388.0K	$1M	$8M	—	—
Q2 24	$102.0K	$2M	$11M	—	—
Q3 24	$421.0K	$3M	$14M	—	—
Q2 25	$128.0K	—	—	$18M	$3M
Q3 25	$270.0K	—	—	$14M	$384.0K

War Chest

Quarter	Cash	Short-term Investments	Total
Q4 23	$2M	$0	$2M
Q1 24	$2M	$0	$2M
Q2 24	$2M	$0	$2M
Q3 24	$3M	$0	$3M
Q4 24	$1M	$0	$1M
Q1 25	$2M	$0	$2M
Q2 25	$4M	$0	$4M
Q3 25	$429.0K	$0	$429.0K
Q4 25	$1M	$0	$1M

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q4 23	50M	—	—
Q1 24	69M	+38.0%	—
Q2 24	59M	-14.3%	—
Q3 24	72M	+22.5%	—
Q4 24	70M	-2.7%	+41.1%
Q1 25	73M	+3.7%	+6.0%
Q2 25	72M	-0.2%	+23.5%
Q3 25	71M	-2.8%	-2.0%
Q4 25	73M	+3.3%	+4.0%

Shares Outstanding

Revenue Per Employee

Period	Revenue/Employee	Employees
Q4 23	$101.4K	79
Q1 24	$124.9K	79
Q2 24	$165.1K	79
Q3 24	$213.5K	79
Q4 24	$128.2K	98
Q1 25	$149.2K	98
Q2 25	$207.7K	98
Q3 25	$148.9K	98
Q4 25	$108.5K	115

Revenue / Employee